建滔集团(00148.HK)拟回购不超5亿港元股份
格隆汇9月25日丨建滔集团(00148.HK)宣布,决定根据公司股东于2019年5月27日举行的股东周年大会上授予董事会的一般授权行使其权力,并自今天起开始在联交所购回公司股份。公司预计进行建议股份购回可持续数月,惟视乎市场及其他状况而定。
尽管根据股份购回授权,公司获授权最多于联交所购回1.08亿股股份,相当于股东周年大会日期已发行股份总数之10%,但公司现时预计建议股份购回涉及的金额不会超过5亿港元。
公司认为,公司股份的价值一直被低估,现时成交价并不反映其内在价值。经考虑本公司的营运及财务状况,本公司相信其现有的财务资源足以进行建议股份购回,同时维持其稳健的财务状况以继续本公司的正常营运。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.